Oz M et al. |
Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. |
2002 |
Synapse |
pmid:12325042
|
Ralevic V et al. |
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. |
2002 |
Life Sci. |
pmid:12354577
|
Walter L et al. |
Astrocytes in culture produce anandamide and other acylethanolamides. |
2002 |
J. Biol. Chem. |
pmid:11916961
|
Schäbitz WR et al. |
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. |
2002 |
Stroke |
pmid:12154273
|
Costa B et al. |
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. |
2002 |
Eur. J. Pharmacol. |
pmid:12163107
|
de Lago E et al. |
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. |
2002 |
Eur. J. Pharmacol. |
pmid:12163112
|
Gardiner SM et al. |
Complex regional haemodynamic effects of anandamide in conscious rats. |
2002 |
Br. J. Pharmacol. |
pmid:11959791
|
Ross RA et al. |
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. |
2001 |
Br. J. Pharmacol. |
pmid:11159715
|
Vanheel B and Van de Voorde J |
Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11160613
|
Ralevic V et al. |
Cannabinoid activation of recombinant and endogenous vanilloid receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11672565
|
Christopoulos A and Wilson K |
Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. |
2001 |
Brain Res. |
pmid:11578621
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Tucker RC et al. |
The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways. |
2001 |
Br. J. Pharmacol. |
pmid:11226144
|
Maingret F et al. |
The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1. |
2001 |
EMBO J. |
pmid:11226154
|
Wagner JA et al. |
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. |
2001 |
Eur. J. Pharmacol. |
pmid:11448486
|
Boger DL et al. |
alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11412972
|
Mendizábal VE et al. |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. |
2001 |
Eur. J. Pharmacol. |
pmid:11567656
|
Nogueron MI et al. |
Cannabinoid receptor agonists inhibit depolarization-induced calcium influx in cerebellar granule neurons. |
2001 |
J. Neurochem. |
pmid:11677265
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
RodrÃguez de Fonseca F et al. |
An anorexic lipid mediator regulated by feeding. |
2001 |
Nature |
pmid:11700558
|
Jamshidi N and Taylor DA |
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. |
2001 |
Br. J. Pharmacol. |
pmid:11704633
|
Gurwitz D and Weizman A |
Fatty acid amide hydrolase inhibitors and the marijuana debate. |
2001 |
Lancet |
pmid:11705595
|
Rice AS |
Cannabinoids and pain. |
2001 |
Curr Opin Investig Drugs |
pmid:11575713
|
Karava V et al. |
Anandamide amidohydrolase activity, released in the medium by Tetrahymena pyriformis. Identification and partial characterization. |
2001 |
FEBS Lett. |
pmid:11728445
|
Stamer WD et al. |
Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. |
2001 |
Eur. J. Pharmacol. |
pmid:11730719
|
Hayase T et al. |
Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. |
2001 |
J. Pharm. Pharmacol. |
pmid:11732755
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Smith PJ and McQueen DS |
Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. |
2001 |
Br. J. Pharmacol. |
pmid:11588121
|
Maccarrone M et al. |
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. |
2001 |
Arch. Biochem. Biophys. |
pmid:11556820
|
Crozier Willi G et al. |
Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods. |
2001 |
Nestle Nutr Workshop Ser Clin Perform Programme |
pmid:11510437
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Berger A et al. |
Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11353819
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
López-RodrÃguez ML et al. |
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. |
2001 |
J. Med. Chem. |
pmid:11741470
|
Chemin J et al. |
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. |
2001 |
EMBO J. |
pmid:11742980
|
Möhle R et al. |
Transendothelial migration of hematopoietic progenitor cells. Role of chemotactic factors. |
2001 |
Ann. N. Y. Acad. Sci. |
pmid:11458515
|
Calignano A et al. |
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11426841
|
Di Marzo V et al. |
Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11181068
|
Fride E et al. |
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. |
2001 |
Eur. J. Pharmacol. |
pmid:11426843
|
Ugdyzhekova DS et al. |
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. |
2001 |
Bull. Exp. Biol. Med. |
pmid:11427912
|
Murillo-RodrÃguez E et al. |
Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor. |
2001 |
Neuroreport |
pmid:11447321
|
Sprague J et al. |
Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. |
2001 |
Eur. J. Pharmacol. |
pmid:11448475
|
Porter AC and Felder CC |
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. |
2001 |
Pharmacol. Ther. |
pmid:11448725
|
Laine K et al. |
Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. |
2001 |
Pharm. Res. |
pmid:11451037
|
Holt S et al. |
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen. |
2001 |
Br. J. Pharmacol. |
pmid:11399668
|
Di Marzo V et al. |
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. |
2001 |
Eur. J. Pharmacol. |
pmid:11408034
|
Breivogel CS et al. |
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. |
2001 |
Mol. Pharmacol. |
pmid:11408610
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|